We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NMG
11526
Nouveau Monde Graphite
NMG
$484M
$77K ﹤0.01%
+15,790
New +$90.9K
OGI
11527
Organigram Holdings
OGI
$173M
$77K ﹤0.01%
21,014
+18,154
+635% +$92.6K
WVE icon
11528
CALL
Wave Life Sciences
WVE
$1.07B
$77K ﹤0.01%
+23,800
New +$45.8K
ATYR
11529
PUT
aTyr Pharma
ATYR
$54.8M
$77K ﹤0.01%
27,100
-13,200
-33% -$47.7K
AFIB
11530
DELISTED
Acutus Medical Inc
AFIB
$77K ﹤0.01%
68,419
+52,591
+332% +$45.1K
PHXM
11531
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$77K ﹤0.01%
7,029
+3,632
+107% +$44.9K
ACGN
11532
DELISTED
Aceragen Inc
ACGN
$77K ﹤0.01%
9,874
+7,476
+312% +$63.6K
CEI
11533
PUT
DELISTED
Camber Energy, Inc
CEI
$77K ﹤0.01%
3,882
-4,760
-55% -$163K
AIFA
11534
All In FutureTech Alliance Inc
AIFA
$18.5M
$76K ﹤0.01%
8,856
+5,564
+169% +$51.2K
CTLP
11535
PUT
DELISTED
Cantaloupe
CTLP
$76K ﹤0.01%
13,600
-5,100
-27% -$27.1K
HITI
11536
CALL
High Tide
HITI
$206M
$76K ﹤0.01%
38,400
+8,200
+27% +$24.3K
LNAI
11537
PUT
Lunai Bioworks
LNAI
$10.1M
$76K ﹤0.01%
+493
New +$226K
SNOA icon
11538
Sonoma Pharmaceuticals
SNOA
$6.22M
$76K ﹤0.01%
+1,284
New +$82.2K
MAGN
11539
CALL
Magnera Corp
MAGN
$444M
$76K ﹤0.01%
+846
New +$101K
CSSE
11540
CALL
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$76K ﹤0.01%
+10,200
New +$78.1K
APLT
11541
DELISTED
Applied Therapeutics
APLT
$75K ﹤0.01%
78,843
+62,158
+373% +$102K
CBAT icon
11542
CBAK Energy Technology Ltd
CBAT
$64.1M
$75K ﹤0.01%
69,449
+12,505
+22% +$14.5K
GTE icon
11543
CALL
Gran Tierra Energy
GTE
$325M
$75K ﹤0.01%
6,520
-1,120
-15% -$17.8K
MRAM icon
11544
PUT
Everspin Technologies
MRAM
$460M
$75K ﹤0.01%
14,400
-10,700
-43% -$68.9K
OWLT icon
11545
CALL
Owlet
OWLT
$195M
$75K ﹤0.01%
3,171
-465
-13% -$23K
PPSI
11546
Pioneer Power Solutions
PPSI
$32.3M
$75K ﹤0.01%
+26,461
New +$108K
SEAT icon
11547
CALL
Vivid Seats
SEAT
$80.7M
$75K ﹤0.01%
+500
New +$90.5K
NBIS
11548
CALL
Nebius Group N.V.
NBIS
$75.5B
$75K ﹤0.01%
34,500
-117,500
-77% -$255K
ISUN
11549
PUT
DELISTED
iSun, Inc. Common Stock
ISUN
$75K ﹤0.01%
23,000
+5,400
+31% +$18.2K
OTIC
11550
DELISTED
Otonomy, Inc.
OTIC
$75K ﹤0.01%
36,160
+17,122
+90% +$35.6K

Similar funds

Citadel Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Citadel Advisors held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Citadel Advisors's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Citadel Advisors's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Citadel Advisors added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Citadel Advisors's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Citadel Advisors fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Citadel Advisors's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Citadel Advisors opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Citadel Advisors's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.